Berger Montague Investigates Alleged Ponzi Scheme and Potential Securities Violations and Breaches of Fiduciary Duty Against Zachary Horwitz and 1inMM Capital, LLC
News provided by
Share this article
Share this article
SAN DIEGO, April 8, 2021 /PRNewswire/ Berger Montague is investigating potential securities violations, breaches of fiduciary duty, and other claims against Zachary J. Horwitz ( Horwitz ), 1inMM Capital, LLC ( 1inMM ), and other parties arising out of an alleged Ponzi scheme through which these parties defrauded investors by approximately $690 million over the course of more than five years.
If you purchased promissory notes issued by 1inMM, made investments with Horwitz or 1inMM, have questions concerning your rights or interests, or would like to discuss Berger Montague s investigation, please contact our office at (619) 489-0300 or www.bergermontague.com/zachary-horwitz-ponzi-scheme, or attorneys Andrew Abramowitz at [email protected] or (215) 875-3015, or
Share this article
Share this article
PHILADELPHIA, Feb. 19, 2021 /PRNewswire/ Berger Montague is investigating potential securities fraud claims against bluebird bio, Inc. ( bluebird or the Company ) on behalf of investors who purchased bluebird securities (NASDAQ: BLUE) between
May 11, 2020 and November 4, 2020 (the Class Period ).
If you purchased bluebird securities during the Class Period, have questions concerning your rights or interests, or would like to discuss Berger Montague s investigation, please contact attorneys Andrew Abramowitz at [email protected] or (215) 875-3015, or Donnell Much at [email protected] or (215) 875-4667, or contact us at: www.bergermontague.com/bluebird.
According to a recently filed lawsuit, defendants misled investors during the Class Period by, among other things: (i) failing to disclose that the data supporting bluebird s Biologics License Application ( BLA ) submission for LentiGlobin, a gene therapy intended to treat sickle c
/PRNewswire/ Berger Montague is investigating potential securities fraud claims against Clover Health Investments, Corp. formerly known as Social Capital.
/PRNewswire/ Berger Montague is investigating potential securities fraud claims against QuantumScape Corporation ("QuantumScape" or the "Company") on behalf.